Weedley develops, commercializes, and markets CBD products for pets. Weedley's CBD oil drops, balms, and treats are derived from European-grown organic whole hemp (cannabis sativa), a legally produced substance containing a high concentration of CBD, and are aiming to help to ease cat, dog, and horse problems from anxiety to arthritis. CBD promotes homeostasis, works as an anti-inflammatory, and more. Weedley CBD products are not psychoactive.
The website guides pet owners in choosing the appropriate treatment for their animal and its condition. It's available online, shipped from the company's logistics headquarters in Holland.
In cooperation with Israeli company Pet Pace and its smart collar that analyzes pet health and monitors pain levels, Weedley is researching how CBD can help and treat osteoarthritis symptoms in dogs and cats.
Weedley was formed at the beginning of 2019 as a subsidiary of Gour Medical, a French healthcare company dedicated to the commercialization of veterinary products.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Weedley Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jul 14, 2019
nocamels.com
Cannabis For Animals? Israeli Research Underway To Win Over Global Pet Care Market
#Customers
May 28, 2019
uk.reuters.com
BRIEF-Gour Medical Announces Partnership With Petpace